At Biologics by McKesson, proactive pharmacy care and personalized support help patients stay on therapies, reduce costs and improve outcomes.
30 Years of Patient Empowerment: Biologics’ Journey
Over three decades, Biologics by McKesson enhances medication access and personalized patient support.
Read time: 2 minutes
Personalized patient care has long been considered a cornerstone of quality healthcare. Not only does an individualized approach elevate patient morale in those facing challenging diagnoses, but it can also have a profound impact on improving health outcomes.
From day one, Biologics by McKesson has been dedicated to delivering care tailored to each patient's needs. The specialty pharmacy’s comprehensive services aim to simplify access to therapies, with a focus on oncology and other complex rare diseases. With a multidisciplinary care team, Biologics provides assistance in understanding medications, managing prescriptions, handling side effects, and navigating financial resources to alleviate treatment costs.
As Biologics celebrates its 30th anniversary, it reflects on the many ways it has embodied an unwavering dedication to making a difference in the lives of patients.
Related Stories
Sarah Cannon Research Institute (SCRI) offers clinical trials in communities close to home, where 85% of patients seek care.
How Shenandoah Oncology became a blueprint for compassion and turned patient feedback into a lifeline.
How community oncology clinics are helping break down barriers to care.
How Biopharma and community oncology are working together to solve healthcare’s toughest challenges and build a more resilient future for cancer care.
Meeting the demands of ultra-sensitive treatments with purpose-built storage, automation and pharmacy integration
In the third episode of our Always Advancing video series, learn how precision and personalized medicine are transforming cancer care – expanding access to clinical trials and novel treatments in communities.
Using McKesson Compile’s analytics to transform how patients with rare blood disorders access specialized care across Indiana.
InspiroGene by McKesson helps patients with rare and severe diseases access innovative cell and gene therapies through personalized support at every step of their journey.
In the fourth episode of our Always Advancing video series, discover how InspiroGene by McKesson partners with biopharma to expand patient access to advanced therapies.